Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Octagon Capital Advisors LP's stake in Unicycive Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 10, 2026
Octagon Capital Advisors LP's stake in Unicycive Therapeutics, Inc. fell to 4.70%, 1,000,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 1,000,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Octagon Capital Advisors LP | 4.70% | 1,000,000 |
| Octagon Investments Master Fund LP | 3.00% | 650,000 |
| Octagon Biotech Opportunities Fund I LP | 1.70% | 350,000 |
| Ting Jia | 4.70% | 1,000,000 |
Source
Related
- Unicycive Therapeutics, Inc.
- Octagon Capital Advisors LP
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Octagon Capital Advisors LP · Nov 14, 2025
- Schedule 13G/A · Octagon Capital Advisors LP · Aug 12, 2025
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026